First- and second-generation antipsychotic medication and cognitive processing in schizophrenia (Q36228233)

12 August 2017

1 reference

title

First- and second-generation antipsychotic medication and cognitive processing in schizophrenia (English)

1 reference

12 August 2017

1 reference

Thomas W Weickert

1

1 reference

12 August 2017

Terry E Goldberg

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

12 August 2017

number of pages

7

1 reference

Current Psychiatry Reports

inferred from page(s)

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

304-310

1 reference

Intelligence in schizophrenia: meta-analysis of the research

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Adult schizophrenia with scholastic failure or low IQ in childhood. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Negative v positive schizophrenia. Definition and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

Clinical profile of an atypical antipsychotic: risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11920-005-0085-5

CHILDHOOD INTELLECTUAL DIFFERENCES BETWEEN SCHIZOPHRENIC ADULTS AND THEIR SIBLINGS.

21 January 2018

1 reference

12 December 2020

Another view of therapy for cognition in schizophrenia

1 reference

12 December 2020

Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patients

1 reference

12 December 2020

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

1 reference

12 December 2020

Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents.

1 reference

12 December 2020

What's atypical about atypical antipsychotic drugs?

1 reference

12 December 2020

Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man

1 reference

12 December 2020

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

12 December 2020

The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs

1 reference

12 December 2020

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

1 reference

12 December 2020

Cognitive deficit among remitted schizophrenics: The role of a life-history variable

1 reference

12 December 2020

Independent Transmission of IQ and Schizophrenia

1 reference

12 December 2020

Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input

1 reference

12 December 2020

Influences on cognitive heterogeneity in schizophrenia

1 reference

12 December 2020

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia

1 reference

12 December 2020

Neuropsychological evidence for frontostriatal dysfunction in schizophrenia

1 reference

12 December 2020

Schizophrenia and the myth of intellectual decline

1 reference

12 December 2020

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Learning and memory in monozygotic twins discordant for schizophrenia.

1 reference

12 December 2020

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 reference

12 December 2020

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

12 December 2020

The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials.

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP

1 reference

12 December 2020

Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia

1 reference

12 December 2020

IQ and risk for schizophrenia: a population-based cohort study

1 reference

12 December 2020

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds

1 reference

12 December 2020

Declarative and procedural learning in schizophrenia: a test of the integrity of divergent memory systems

1 reference

12 December 2020

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

1 reference

12 December 2020

Neuroleptic affinities for human brain receptors and their use in predicting adverse effects

1 reference

12 December 2020

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Abnormalities of fine motor control in schizophrenia

1 reference

12 December 2020

Genetic and neurochemical modulation of prefrontal cognitive functions in children.

1 reference

12 December 2020

Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis

1 reference

12 December 2020

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

1 reference

12 December 2020

Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect

1 reference

12 December 2020

Memory in schizophrenia: what is impaired and what is preserved?

1 reference

12 December 2020

Intelligence, psychopathology, and primary thinking disorder in early schizophrenia

1 reference

12 December 2020

Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.

1 reference

12 December 2020

Clozapine: new research on efficacy and mechanism of action

1 reference

12 December 2020

School Performance of Adult Schizophrenics, Their Siblings and Age Mates

1 reference

12 December 2020

Assessment of the dysexecutive syndrome in schizophrenia

1 reference

12 December 2020

The D2 receptor occupancy profile of loxapine determined using PET.

1 reference

12 December 2020

Cognitive function in schizophrenia--do neuroleptics make a difference?

1 reference

12 December 2020

Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing

1 reference

12 December 2020

Preliminary associations between motor procedural learning, basal ganglia T2 relaxation times, and tardive dyskinesia in schizophrenia

1 reference

12 December 2020

Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications

1 reference

12 December 2020

Guanfacine treatment of cognitive impairment in schizophrenia

1 reference

12 December 2020

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study

1 reference

12 December 2020

The effects of neuroleptics on neuropsychological test results of schizophrenics

1 reference

12 December 2020

EARLY CHILDHOOD INTELLECTUAL DIFFERENCES BETWEEN SCHIZOPHRENIC ADULTS AND THEIR SIBLINGS

1 reference

12 December 2020

Is it possible to be schizophrenic yet neuropsychologically normal?

1 reference

12 December 2020

Genes and the parsing of cognitive processes

1 reference

12 December 2020

Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.

1 reference

12 December 2020

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

12 December 2020

Child development risk factors for adult schizophrenia in the British 1946 birth cohort

1 reference

12 December 2020

Chidhood precursors of psychiosis as clues to its evolutionary orgins

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies

1 reference

12 December 2020

Dopamine and antipsychotic drug action revisited

1 reference

12 December 2020

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

1 reference

12 December 2020

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

1 reference

12 December 2020

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

12 December 2020

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

12 December 2020

The composition of the negative syndrome of chronic schizophrenia

1 reference

12 December 2020

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

1 reference

12 December 2020

Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia

1 reference

12 December 2020

Cognitive functioning and symptomatology in chronic schizophrenia

1 reference

12 December 2020

Pharmacogenetics of psychotropic drug response

1 reference

12 December 2020

A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

10.1007/S11920-005-0085-5

Identifiers

DOI

1 reference

12 August 2017

1 reference